首页> 外文期刊>Journal of Clinical Oncology >Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
【24h】

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

机译:坏死在少突神经胶质肿瘤分级中的意义:新诊断的高级别神经胶质瘤的临床病理和遗传研究。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: High-grade gliomas (HGGs; WHO grades 3-4) are highly diverse, with survival times ranging from months to years. WHO 2000 grading criteria for high-grade oligodendroglial neoplasms [anaplastic oligoastrocytoma (AOA) and anaplastic oligodendroglioma (AO)] remain subjective, and the existence of grade 4 variants is controversial. PATIENTS AND METHODS: Overall survival (OS) of 1,093 adult patients with a cerebral HGG newly diagnosed between 1990 and 2005 was analyzed by univariate and multivariate models for significance of the following factors: patient age, surgery type, year of diagnosis, endothelial proliferation, necrosis, oligodendroglial histology, treatment center, and chromosome 1p, 19q, 7p (EGFR), and 10q (PTEN) abnormalities by fluorescence in situ hybridization (FISH). RESULTS: Necrosis was a statistically significant predictor of poor OS on univariate and multivariate analyses in AOA but not in AO. Median OS for patients with necrotic AOA (22.8 months) was significantly worse than forpatients with non-necrotic AOA (86.9 months; P < .0001) but was better than conventional glioblastomas (9.8 months; P < .0001). In addition to patient age, the following were significant independent prognostic factors (P .001): grade and surgery type for the entire HGG cohort; modified grade for AOA (3 v 4); and modified grade, 1p/19q codeletion status, and oligodendroglial histology for the 586 HGGs analyzed by FISH. CONCLUSION: Stratification of AOA, but not of pure AO, into grades 3 and 4 on the basis of necrosis is prognostically justified and is more powerful than the current approach. Both routine histology and genetic testing provide independent, prognostically useful information.
机译:目的:高级神经胶质瘤(HGG; WHO 3-4级)高度多样化,生存时间从数月到数年不等。 WHO 2000年对高级别少突神经胶质瘤的分级标准[间变性少星形胶质细胞瘤(AOA)和间变性少突神经胶质瘤(AO)]仍然是主观的,并且存在4级变体存在争议。病人与方法:采用单因素和多因素模型分析了1990年至2005年之间新诊断的1,093例患有脑HGG的成年患者的总生存(OS),了解以下因素的重要性:患者年龄,手术类型,诊断年份,内皮细胞增生,坏死,少突神经胶质组织学,治疗中心和1p,19q,7p(EGFR)和10q(PTEN)染色体异常通过荧光原位杂交(FISH)检测。结果:在AOA中单因素和多因素分析中,坏死是OS差的统计学显着预测因子,而在AO中则没有。坏死性AOA患者的中位OS(22.8个月)显着低于非坏死性AOA患者的OS(86.9个月; P <.0001),但优于传统的胶质母细胞瘤(9.8个月; P <.0001)。除患者年龄外,以下是重要的独立预后因素(P <0.001):整个HGG队列的等级和手术类型;修改后的AOA等级(3 v 4);并通过FISH分析了586例HGG的改良分级,1p / 19q编码状态和少突神经胶质组织学。结论:基于坏死,将AOA而非纯AO分层为3级和4级在预后上是合理的,并且比目前的方法更有效。常规组织学和基因检测均提供独立的,对预后有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号